Targeting RBM5 may help disrupt ‘undruggable’ MYC in childhood leukemia (IMAGE)

St. Jude Children's Research Hospital

Targeting RBM5 may help disrupt ‘undruggable’ MYC in childhood leukemia

Caption

Co-corresponding author Chunliang Li, PhD, St. Jude Department of Tumor Cell Biology.

Credit

St. Jude Children's Research Hospital

Usage Restrictions

No cropping

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.